These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 25165191)

  • 1. Spanish guidelines for the management of autosomal dominant polycystic kidney disease.
    Ars E; Bernis C; Fraga G; Martínez V; Martins J; Ortiz A; Rodríguez-Pérez JC; Sans L; Torra R;
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv95-105. PubMed ID: 25165191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus document on autosomal dominant polycystic kindey disease from the Spanish Working Group on Inherited Kindey Diseases. Review 2020.
    Ars E; Bernis C; Fraga G; Furlano M; Martínez V; Martins J; Ortiz A; Pérez-Gómez MV; Rodríguez-Pérez JC; Sans L; Torra R;
    Nefrologia (Engl Ed); 2022; 42(4):367-389. PubMed ID: 36404270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autosomal dominant policystic kidney disease, more than a renal disease.
    Torra R
    Minerva Endocrinol; 2014 Jun; 39(2):79-87. PubMed ID: 24736482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and management.
    Luciano RL; Dahl NK
    Nephrol Dial Transplant; 2014 Feb; 29(2):247-54. PubMed ID: 24215018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autosomal dominant polycystic kidney disease: pathophysiology and treatment.
    McCarthy S; McMullen M
    ANNA J; 1997 Feb; 24(1):45-51; quiz 52-3. PubMed ID: 9146123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease.
    Spithoven EM; Kramer A; Meijer E; Orskov B; Wanner C; Caskey F; Collart F; Finne P; Fogarty DG; Groothoff JW; Hoitsma A; Nogier MB; Postorino M; Ravani P; Zurriaga O; Jager KJ; Gansevoort RT; ; ; ; ;
    Kidney Int; 2014 Dec; 86(6):1244-52. PubMed ID: 24827775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of patients in England and Wales with autosomal dominant polycystic kidney disease and end-stage renal failure.
    Shaw C; Simms RJ; Pitcher D; Sandford R
    Nephrol Dial Transplant; 2014 Oct; 29(10):1910-8. PubMed ID: 24737444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The screening, diagnosis, and management of patients with autosomal dominant polycystic kidney disease: A national consensus statement from Taiwan.
    Yen PW; Chen YA; Wang W; Mao FS; Chao CT; Chiang CK; Lin SH; Tarng DC; Chiu YW; Wu MJ; Chen YC; Kao JT; Wu MS; Lin CL; Huang JW; Hung KY
    Nephrology (Carlton); 2024 May; 29(5):245-258. PubMed ID: 38462235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic and renal manifestations in autosomal dominant polycystic kidney disease: a dichotomy of two ends of a spectrum.
    van Gulick JJ; Gevers TJ; van Keimpema L; Drenth JP
    Neth J Med; 2011 Sep; 69(9):367-71. PubMed ID: 21978978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the clinical management of autosomal dominant polycystic kidney disease.
    Torra R
    F1000Res; 2019; 8():. PubMed ID: 30755792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in management of autosomal-dominant polycystic kidney disease.
    Potts JW; Mousa SA
    Am J Health Syst Pharm; 2017 Dec; 74(23):1959-1968. PubMed ID: 29167138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spectrum of autosomal dominant polycystic kidney disease in children and adolescents.
    Reddy BV; Chapman AB
    Pediatr Nephrol; 2017 Jan; 32(1):31-42. PubMed ID: 27034070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of renal replacement therapy in autosomal dominant polycystic kidney disease.
    Pirson Y; Christophe JL; Goffin E
    Nephrol Dial Transplant; 1996; 11 Suppl 6():24-8. PubMed ID: 9044324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Area Data Standards for Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC).
    Perrone RD; Neville J; Chapman AB; Gitomer BY; Miskulin DC; Torres VE; Czerwiec FS; Dennis E; Kisler B; Kopko S; Krasa HB; LeRoy E; Castedo J; Schrier RW; Broadbent S
    Am J Kidney Dis; 2015 Oct; 66(4):583-90. PubMed ID: 26088508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying and integrating consumer perspectives in clinical practice guidelines on autosomal-dominant polycystic kidney disease.
    Tong A; Tunnicliffe DJ; Lopez-Vargas P; Mallett A; Patel C; Savige J; Campbell K; Patel M; Tchan MC; Alexander SI; Lee V; Craig JC; Fassett R; Rangan GK
    Nephrology (Carlton); 2016 Feb; 21(2):122-32. PubMed ID: 26235729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autosomal dominant polycystic kidney disease: a case study.
    Phillips A
    Nephrol Nurs J; 2009; 36(1):41-7. PubMed ID: 19271623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
    Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Bae KT; Baumgarten DA; Kenney PJ; King BF; Glockner JF; Wetzel LH; Brummer ME; O'Neill WC; Robbin ML; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
    Kidney Int; 2003 Sep; 64(3):1035-45. PubMed ID: 12911554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardised Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD): study protocol for establishing a core outcome set in polycystic kidney disease.
    Cho Y; Sautenet B; Rangan G; Craig JC; Ong ACM; Chapman A; Ahn C; Chen D; Coolican H; Kao JT; Gansevoort R; Perrone R; Harris T; Torres V; Pei Y; Kerr PG; Ryan J; Gutman T; Howell M; Ju A; Manera KE; Teixeira-Pinto A; Hamiwka LA; Tong A
    Trials; 2017 Nov; 18(1):560. PubMed ID: 29169385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic, diagnostic and therapeutic characteristics of autosomal dominant polycystic kidney disease in Ghana.
    Okyere P; Ephraim RKD; Okyere I; Attakorah J; Serwaa D; Essuman G; Abaka-Yawson A; Adoba P
    BMC Nephrol; 2021 Apr; 22(1):156. PubMed ID: 33910506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Chapman AB; Devuyst O; Eckardt KU; Gansevoort RT; Harris T; Horie S; Kasiske BL; Odland D; Pei Y; Perrone RD; Pirson Y; Schrier RW; Torra R; Torres VE; Watnick T; Wheeler DC;
    Kidney Int; 2015 Jul; 88(1):17-27. PubMed ID: 25786098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.